In crisis? Call or text 988 in the US for the Suicide and Crisis Lifeline.

How we verify For clinics Sign in
KetamineDrs
Claim or create your clinic

Find care

Search all clinics Browse by state Conditions treated Treatment types

Learn

Articles Guides Glossary Questions and answers

Clinics

List or claim your clinic How verification works Sign in

Appearance

Owen Barreto

Investigations reporter
Owen writes about pricing, marketing claims and the regulatory grey areas in the ketamine clinic market. Reporting here is built on published trial data, regulatory filings and pricing collected directly from clinics rather than from press material.
5Articles written
0Articles reviewed
5Guides in the library

Articles by Owen Barreto

Everything published under this byline.
Evidence and research What the ketamine research does not tell us yet Durability, optimal maintenance intervals, and long-term safety of repeated low-dose use. Three open questions that matter more than … 2,589 words
State coverage Rural access to ketamine treatment is a clinical problem, not a logistical one Six visits in three weeks, each needing a driver. Distance stops being an inconvenience and becomes a reason … 2,639 words
Evidence and research Why six infusions, and what the research says about what comes after The six-session induction is a convention inherited from early trials, not a figure settled by comparative research. Maintenance … 2,628 words
Cost and access Does insurance cover ketamine therapy? A state-by-state reality check Commercial insurance rarely reimburses off-label intravenous administration. Esketamine changes the calculation in ways worth understanding. 2,706 words
Evidence and research The difference between Spravato and IV ketamine, explained without the marketing One is FDA-approved and often insurable. The other is off-label and usually is not. Clinic websites blur the … 2,720 words